1. Dimitropoulos G, Tahrani AA, Stevens MJ. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes 2014; 5 (1): 17–39. doi: 10.4239/wjd.v5.i1.17.
2. Vinik AI, Erbas T. Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med 2001; 68: 928–30.
3. Dyck PJ, Kratz KM, Karnes JL et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43: 817–24.
4. Neil HA, Thompson AV, John S et al. Diabetic autonomic neuropathy: the prevalence of impaired heart rate variability in a geographically defined population. Diabet Med 1989; 6: 20–4.
5. Verrotti A, Chiarelli F, Blasetti A, Morgese G. Autonomic neuropathy in diabetic children. J Paediatr Child Health 1995; 31: 545–8.
6. Филиппов Ю.А. Гастроэнтерологические нарушения при диабетической нейропатии. Врач. 2011; 4: 96–101.
7. Duchen LW, Anjorin A, Watkins PJ, Mackay JD. Pathology of autonomic neuropathy in diabetes mellitus. Ann Intern Med 1980; 92: 301–3.
8. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985; 8: 491–8.
9. Балаболкин М.И., Чернышова Т.Е., Трусов В.В., Гурьева И.В. Диабетическая нейропатия: патогенез, диагностика, классификация, прогностическое значение, лечение: Учеб.-метод. пособие. М., 2003.
10. Peppa M, Uribarri J, Vlassara H. Glucose, Advanced Glycation End Products, and Diabetes Complications: What Is New and What Works. Clin Diabetes 2003; 21 (4): 186–7.
11. Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: The oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord 2008; 9 (4): 301–14.
12. Hermann R, Niebch G. Human pharmacokinetics of a-lipoic acid. In book «Lipoic acid in health and disease». Eds. Fuchs J, Packer L, Zimmer G. Marcel Dekker Inc N-Y 1997; p. 337–60.
13. Gleiter CH, Schug BS, Hermann R et al. Influence of food intake on the bioavailability of thioctic eneantiomers. Eur J Clin Pharmacol 1996; 50: 513–4.
14. Ziegler D, Ametov A, Barinov A et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006; 29: 2365–70.
Авторы
О.В.Котова
НИО неврологии НИЦ ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава России